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ABSTRACT
Background We report the prevalence, risk factors and mortality associated with multimorbidity in urban South Asian adults.
Methods Hypertension, diabetes, heart disease, stroke and chronic kidney disease were measured at baseline in a sample of 16 287 adults
ages ≥20 years in Delhi, Chennai and Karachi in 2010–11 followed for an average of 38 months. Multimorbidity was deﬁned as having ≥2
chronic conditions at baseline. We identiﬁed correlates of multimorbidity at baseline using multinomial logistic models, and we assessed the
prospective association between multimorbidity and mortality using Cox proportional hazards models.
Results The adjusted prevalence of multimorbidity was 9.4%; multimorbidity was highest in adults who were aged ≥60 years (37%), consumed
alcohol (12.3%), body mass index ≥25m/kg2 (14.1%), high waist circumference (17.1%) and had family history of a chronic condition (12.4%).
Compared with adults with no chronic conditions, the fully adjusted relative hazard of death was twice as high in adults with two morbidities (hazard
ratio [HR] = 2.3; 95% conﬁdence interval [CI]: 1.6, 3.3) and thrice as high in adults with ≥3 morbidities (HR = 3.1; 95% CI: 1.9, 5.1).
Conclusion Multimorbidity affects nearly 1 in 10 urban South Asians, and each additional morbidity carries a progressively higher risk of death.
Identifying locally appropriate strategies for prevention and coordinated management of multimorbidity will beneﬁt population health in the region.
Keywords chronic disease, mortality, multimorbidity, South Asia
Introduction
Rapid aging of populations in low- and middle-income
countries (LMIC) has resulted in a rise in chronic condi-
tions, and there is heightened concern regarding the health
of individuals living with multiple chronic conditions, or
multimorbidity.1 Experiencing multimorbidity—compared
with single morbidity in isolation—is associated with higher
disability, lower self-rated health and lower quality of life.2–5
Furthermore, multimorbidity is costly and taxing to patients
and the health system,6,7 especially in LMICs such as India
and Pakistan7 where the complexities of managing multiple
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conditions poses a signiﬁcant challenge for primary health-
care physicians.8
The few recent studies on multimorbidity in South Asia
have been limited to self-reported morbidity data without
objective measures to ascertain undiagnosed conditions.
Furthermore, we are not aware of any population-based
studies that document the risk of death associated with mul-
timorbidity in South Asia. To ﬁll this gap, we draw on a
population-based cohort of urban adults in India and
Pakistan with objective assessments on ﬁve highly prevalent
chronic conditions: hypertension, diabetes, heart disease,
stroke and chronic kidney disease. The aims of the present
study were 2-fold: (i) to examine the sociodemographic and
health correlates of prevalent single and multimorbidity at
baseline and (ii) to prospectively examine the association of
single and multimorbidity with mortality.
Methods
Study design and analytic sample
Data were from the Cardiometabolic Risk Reduction in
South Asia Surveillance Study (CARRS Surveillance Study).
The participants constitute a population-based, representa-
tive sample of urban adults in Chennai, New Delhi and
Karachi in 2010–119 followed to measure cardiometabolic
diseases and their risk factors. Details of the CARRS study
design have previously been published.9 In brief, participants
were selected in each of the three cities using a multistage
cluster random sampling technique. At the ﬁrst stage, pri-
mary sampling units were municipal sub-divisions (wards in
Chennai and Delhi and clusters in Karachi). Next, house-
holds were sampled with equal opportunity for selection. In
each household, one man and one woman aged ≥20 years
were selected using the Kish method.10 Pregnant women (as
the body and blood measurements would be different from
general population) and bed-ridden individuals (inability to
complete detailed questionnaire and measurements) were
excluded. All the participants provided written informed
consent prior to enrollment/participation in the study.
Trained ﬁeld teams gathered data using standardized tech-
niques.9 Data were collected from participants through inter-
views in local languages, clinical examinations and laboratory
analysis of blood samples collected either at mobile clinics
set up in participants’ neighborhoods (Chennai, Delhi) or in
participants’ homes (Karachi). The baseline response rate
was 94.7% for questionnaire completion and 84.3% for
blood sample collection.
The present study includes baseline data from the three
CARRS study sites collected between October 2010 and
November 2011 with mortality follow-up through June
2014. The primary analysis includes data from all 16 287
men and women enrolled at baseline.
Chronic conditions and multimorbidity at baseline
We assessed the presence of ﬁve chronic conditions at base-
line using the following criteria: hypertension (self-report of
prior diagnosis, measured blood pressure [BP] of 140/
90 mmHg or above, or taking medication); diabetes (self-
report, fasting plasma glucose of ≥126 mg/dL or HbA1c of
≥6.5, or taking medication); heart disease (self-report);
stroke (self-report); chronic kidney disease (self-report
[Karachi site], probable kidney disease based on applying the
2012 Kidney Disease International Global Outcomes CKD
guidelines of albumin-to-creatinine ratio ≥30 mg/g, or
Estimated Glomerular Filtration Rate [eGFR] <60 ml/min/
1.73 m [New Delhi and Chennai sites]).11 We relied on self-
reported CKD at the Karachi site due to the unavailability
of appropriate assay technology needed to measure creatin-
ine per internationally recognized standards. Multimorbidity
was deﬁned as having two or more of these ﬁve chronic
conditions at baseline.
Participant follow-up and ascertainment of death
Participants were contacted annually by phone (third follow-
up assessment) or in-person (ﬁrst and second follow-up
assessment). Vital status for deceased participants was veri-
ﬁed through verbal autopsy interviews with next of kin.
Participants included in the mortality analysis were followed
for an average of 38 months (range: minimum of 13 months
to maximum of 51 months). All of the 320 deaths ascer-
tained through June 2014 were included in this analysis.
Covariates
Demographic variables of interest included age, sex, occupa-
tion and education. We classiﬁed participant occupation into
ﬁve mutually exclusive categories: students and housewives
(not in the labor force); retired (not presently in the labor
force but previously working); unemployed (in the labor
force, but not currently working); manual profession or
small business (employed in a physically demanding job);
professional (employed in a non-physically demanding job).
Education was measured using the highest level of education
and categorized as up to primary schooling (up to Class 4),
high school to secondary (Classes 5–12), and college gradu-
ation (Bachelor’s degree) and above. Due to a strong correl-
ation between education and an index of household assets
(r = 0.38) we did not include the index of household assets
in the analysis.
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The health risk factors consisted of current tobacco use
(current daily versus non-daily users), current alcohol con-
sumption (regular or occasional user in the last 6 months
versus no alcohol use in the last >6 months), body mass
index (BMI, kg/m2), waist circumference (cm) and family
history (history of hypertension, diabetes, stroke and heart
disease versus no family history).
Statistical analysis
We used multinomial logistic regression to estimate the
adjusted prevalence (marginal predicted probability) of zero,
single (one chronic condition in isolation at baseline) and
multimorbidity (two or more chronic conditions at baseline)
by sociodemographic and health-related factors of interest.
We also report the associations (prevalence ratios) of socio-
demographic and health-related factors with single and mul-
timorbidity (reference = no chronic conditions) from multinomial
logistic regression models including all sociodemographic and
health-related factors simultaneously.
We next used Poisson regression models to compute age-
adjusted mortality (deaths per 1000 person-years) by socio-
demographic and health-related variables of interest. Finally,
we evaluated the hazard ratio (HR) of death associated with
multimorbidity and sociodemographic and health-related
factors using Cox proportional hazards models that were
fully adjusted for all predictors.
We found that 32% of participants were missing a covariate
needed for the analysis (Fig. 1). To utilize data from all partici-
pants while minimizing bias due to exclusions, analyses were
performed using multiple imputed data to account for missing
covariates. Multiple imputation was conducted using the
chained equation approach.12 We used a fully conditional speci-
ﬁcation method to impute missing covariates. The imputation
model contained age; sex; education; occupation; family history
of hypertension, diabetes, stroke and heart disease; height;
weight; waist; FPG; HbA1c level; and systolic and diastolic BP.
We also assessed convergence by plotting means and standard
deviations by iteration and imputation. We conducted 10 impu-
tations and analyzed the results according to convention.12 All
primary analyses are based on the multiply imputed data.
A supplemental sensitivity analysis of prevalent multimor-
bidity at baseline was restricted to the 10 792 participants
with complete laboratory assessments (FPG, systolic BP and
albumin), anthropometric measurements (height, weight and
waist), awareness of family history and sociodemographic
data of interest. A second supplemental sensitivity analysis
of mortality was conducted using data from the 10 787 parti-
cipants for whom we knew the exact date of last follow-up
or death, needed for survival analysis.
We accounted for the complex survey design in all ana-
lyses by adjusting standard errors for clustering and incorp-
orating sampling weights. Estimates of prevalence and
associations were age- and sex-standardized to the 2010
South Asia regional population.13 All statistical test values
were two-sided, and a P < 0.05 was considered as statistic-
ally signiﬁcant. Analyses were performed using Stata soft-
ware (version 12.1; Stata Corporation, College Station, TX).
Results
Table 1 displays the baseline characteristics of the 16 287
participants comprising the CARRS cohort. The average age
of the participants at baseline was 41.0 (95% conﬁdence inter-
val [CI]: 40.0, 42.0) years. Overall, 52.7% were women,
18.1% had completed college and 47.8% were employed. The
prevalence of each individual condition was as follows: hyper-
tension, 31.1% (29.4%, 32.9%); diabetes, 23.5% (22.0%,
25.0%); heart disease, 2.4% (2.1%, 2.8%); stroke, 0.4% (0.3%,
0.5%); and chronic kidney disease, 7.3% (5.8%, 8.9%). With
respect to speciﬁc comorbidities, diabetes and hypertension
was the most prevalent combination observed (11.0% in the
total population; data not shown). Over half (56.6%) of the
sample had no chronic conditions, 28.6% experienced single
morbidity and 14.7% experienced multimorbidity at baseline.
Multimorbidity and its correlates
Table 2 shows adjusted prevalence and the adjusted prevalence
ratios of demographic and socioeconomic factors associated
with single and multimorbidity relative to no chronic condi-
tions from a multinomial logistic regression model. We found
that 30.2% (28.9%, 31.5%) participants had at least one
chronic condition and that 9.4% (8.7%, 10.1%) had two or
more chronic conditions. The prevalence of multimorbidity
was 10% in those younger than 60 years and 37% in adult’s
aged ≥60 years, and each year of age was associated with 11%
higher relative prevalence of multimorbidity (PR = 1.11; 1.10,
1.11). Compared with those with primary school education or
below, college graduates and higher had lower single morbidity
(PR = 0.85; 0.72, 0.99) and multimorbidity (PR = 0.76; 0.61,
0.96). Similarly, those employed in manual labor were less
likely to have multimorbidity than the professionally employed
(PR = 0.68; 0.53, 0.87). Alcohol consumption (PR = 1.68;
1.39, 2.01), BMI (PR = 1.04; 1.02, 1.06) and waist circumfer-
ence (PR = 1.05; 1.04, 1.06) were positively associated with
the prevalent multimorbidity. Having a positive family history
for any one of the conditions was associated with nearly twice
the prevalence of multiple comorbidities (PR = 1.79; 1.58,
2.03). There were no associations between gender or tobacco
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consumption and single or multimorbidity after adjusting for
other covariates.
Multimorbidity and age-adjusted mortality
Table 3 displays age-adjusted mortality alongside adjusted
HR by sociodemographic and health factors of interest. The
total age-adjusted mortality was 8.2 (95% CI: 7.9, 8.5) deaths
per 1000 person-years. For individuals with no chronic con-
ditions, age-adjusted mortality was 3.2 per 1000; the corre-
sponding mortality in adults with single and multimorbidity
were 3.6 and 5.1 per 1000 person years, respectively. After
adjusting for sociodemographic and health-related factors,
mortality was 36% (HR = 1.36; 0.94, 1.97) higher in those
with single morbidity and 145% (HR = 2.45; 1.72, 3.49)
higher in those with multimorbidity. In Fig. S2 and
Supplemental Table 1, we show that even among those with
multimorbidity, having more than three conditions was asso-
ciated with higher mortality than having only two conditions
(HR = 2.3; 1.6, 3.3 for two morbidities versus none; HR =
3.1; 1.9, 5.1 for three conditions versus none).
With respect to demographic factors, we observed a posi-
tive association between age and mortality in the fully adjusted
model, but no differences in mortality were observed by gen-
der. Education was strongly and inversely associated with
mortality in the fully adjusted models (relative to the group with
CARRS baseline cohort
n = 16288
n = 10787
Participants with
complete data
n = 3394 
Missing a  biomarker for chronic disease definition
n = 180
Does not know the family history of hypertension, diabetes, 
heart disease
n = 5500
Participants with imputed data
n = 1921
Missing anthropometry
n = 5
Missing date of death
n = 1
Transgender 
individual
excluded
n = 16287
Participants analyzed
17274 adults invited for 
participation. 
n = 986 refused 
(94.3% response rate)
Fig. 1 Participant exclusion criteria and sample size after each stage of restriction.
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less than primary school: HR = 0.66; 0.48, 0.89 for high school
to secondary; HR = 0.32; 0.19, 0.53 for college graduates and
above). Relative to individuals with professional employment,
the unemployed were three times more likely to experience
death (HR = 2.91; 1.58, 5.35); we found no other statistically
signiﬁcant differences between employment groups and mor-
tality. Although not statistically signiﬁcant in the fully adjusted
model, tobacco and alcohol were positively, whereas BMI and
waist circumference were inversely, related to mortality.
We repeated the analyses using complete-case data and
observed similar results (see Supplemental Tables 2 and 3).
Discussion
Main ﬁndings of this study
We evaluated the prevalence, correlates, and mortality risks
associated with multimorbidity in adults in three large cities
in South Asia. To our knowledge, this is among the ﬁrst
population-based reports of mortality risk associated with
multiple morbidities in this region. We found that roughly
40% of participants had at least one of the ﬁve chronic con-
ditions examined, while 9.4% of participants suffered from
multimorbidity. Relative to those with no morbidities, having
either single or multiple chronic morbidities increased the
risk death from any cause. After adjustment for potentially
confounding factors, the relative hazard of death for single
morbidity and multimorbidity compared to no morbidity
was higher by 36 and 145%, respectively.
Our ﬁndings suggest that in the urban South Asian con-
text, chronic conditions often manifest simultaneously.
Particularly the combination of diabetes and hypertension
was highly prevalent. As public health systems are adapting
to address the burden of non-communicable diseases, it will
be important to consider such conditions in combination for
effective response.
What is already known on this topic
The information on prevalence, risk factors, and impacts of
multimorbidity in LMICs is limited. Recently, WHO’s Global
Ageing and Adult Health (SAGE) study estimated prevalence
of multimorbidity in India as 24%, which was comparable to
the prevalence observed in Mexico (27%), Ghana (23%) and
China (22%) but lower than South Africa (32%) or Russia
(50%).14 However, other studies of South Asian adults report
highly variable prevalence estimates of multimorbidity—from
5 to 83% according to one review—in part due to differences
regarding which chronic conditions are included in the deﬁn-
ition of multimorbidity.15
Because morbidities accumulate with age, the most consist-
ent risk factor for multimorbidity in the South Asian studies is
older age.14,15 Although there is some controversy in South
Asia regarding whether chronic conditions are an afﬂiction of
the wealthy and have lesser impact on the poor16 or present
among individuals across the socioeconomic spectrum,17 mul-
timorbidity tends to be higher among individuals with higher
socioeconomic position.14,15,18 Drawing on cross-national
comparison of China and Ghana, researchers have suggested
that the burden of multimorbidity is expected to shift from
advantaged to disadvantaged populations as a country eco-
nomically develops.19
Prior studies have shown that a higher number of chronic
conditions within individuals is associated with higher
Table 1 Participant characteristics
Sociodemographic characteristics Prevalence or mean
[95% CI]
Age, years, mean 41.0 [40.0,42.0]
Gender, %
Men 47.3 [42.0,52.6]
Women 52.7 [47.4,58.0]
Educational attainment, %
Up to primary schooling 20.9 [19.1,22.7]
High school to secondary 61.0 [59.0,63.0]
College and above 18.1 [16.1,20.0]
Employment, %
Not in the labor force, student/housewives 44.3 [40.0,48.7]
Not in the labor force, retired 3.8 [2.9,4.6]
Unemployed 4.2 [3.6,4.7]
Employed in a manual profession 34.5 [31.1,37.9]
Employed in a non-manual professional 13.3 [11.5,15.0]
Health-related risk factors
Current alcohol consumption, % 14.7 [12.8,16.5]
Current tobacco consumption, % 23.0 [21.1,25.1]
Anthropometry
BMI, m/kg2, mean 25.4 [25.1,25.6]
Waist circumference, cm, mean 85.8 [85.2,86.4]
Family history of chronic conditions, %
Hypertension 21.5 [20.2,22.8]
Diabetes 26.8 [25.2,28.4]
Heart disease 10.5 [9.4,11.5]
Chronic condition status
Single chronic conditions
Hypertension,% 31.1 [29.4,32.9]
Diabetes,% 23.5 [22.0,25.0]
Heart disease,% 2.4 [2.1,2.8]
Stroke, % 0.4 [0.3,0.5]
Chronic kidney disease, % 7.3 [5.8,8.9]
Total number of chronic conditions
0 56.6 [54.6,58.6]
1 (Single morbidity) 28.6 [27.4,29.8]
≥2 (Multimorbidity) 14.7 [13.5,16.0]
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Table 2 Sociodemographic and risk factor correlates of multimorbidity in urban South Asian adults
Adjusted prevalence of single and multimorbiditya, % Adjusted prevalence ratiosb
No chronic
conditions
Any one chronic
condition
≥2 Chronic
conditions
Any one chronic
condition versus no
chronic conditions
≥2 Chronic condition
versus no
chronic conditions
MP [CI] MP [CI] MP [CI] PR [CI]a PR [CI]
Total population 60.4 [59.0,61.8] 30.2 [28.9,31.5] 9.4 [8.7,10.1]
Agec
Age < 60 years 62.6 [60.8,64.4] 27.2 [25.9,28.5] 10.2 [9.2,11.1] n/a n/a
Age ≥ 60 years 21.9 [19.8,23.9] 41.2 [39.1,43.4] 36.9 [34.2 ,39.6] n/a n/a
Age, years n/a n/a n/a 1.06 [1.05,1.07] 1.11 [1.10,1.11]
Gender
Men 56.2 [54.1,58.4] 34.5 [32.4,36.5] 9.3 [8.4,10.2] Ref Ref
Women 62.1 [60.2,64.0] 28.3 [26.7,30.0] 9.6 [8.6,10.6] 0.96 [0.78,1.19] 1.23 [0.92,1.58]
Education
Up to primary schooling 60.2 [57.8,62.5] 30.2 [28,32.3] 9.7 [8.5,10.9] Ref Ref
High school to secondary 59.2 [57.4,61] 31 [29.2,32.8] 9.8 [9,10.6] 1.04 [0.92,1.18] 1.02 [0.89,1.18]
Graduation and above 64.5 [61.9,67.2] 27.6 [25.3,29.8] 7.9 [6.7,9.1] 0.85 [0.72,0.99] 0.76 [0.61,0.97]
Occupation
Employed, professional 57.9 [54.2,61.6] 31.3 [28,34.5] 10.8 [8.7,12.9] Ref Ref
Not in the labor force, student or housewife 59.9 [57.3,62.6] 29.8 [27.4,32.3] 10.2 [9.1,11.4] 0.92 [0.75,1.14] 0.91 [0.68,1.23]
Not in the labor force, retired 59.9 [52,67.9] 30 [23.9,36.2] 10 [6.9,13.1] 0.93 [0.65,1.33] 0.89 [0.56,1.42]
Unemployed 57.2 [52.2,62.3] 33.5 [29,38.1] 9.3 [6.8,11.8] 1.08 [0.84,1.39] 0.87 [0.62,1.20]
Employed, manual professional 62.3 [59.9,64.6] 29.8 [27.7,31.9] 7.9 [6.9,8.9] 0.89 [0.75,1.04] 0.68 [0.53,0.87]
Current alcohol consumption
No 61.9 [60.5,63.4] 29.1 [27.8,30.5] 8.9 [8.2,9.6] Ref Ref
Yes 51.1 [48.4,53.8] 36.6 [33.9,39.2] 12.3 [10.6,14.1] 1.52 [1.34,1.72] 1.68 [1.39,2.01]
Current tobacco consumption
No 60.4 [58.7,62] 30.2 [28.6,31.8] 9.4 [8.7,10.2] Ref Ref
Yes 60.5 [58.1,62.9] 30.2 [28.2,32.3] 9.3 [8.1,10.5] 0.99 [0.88,1.14] 0.98 [0.83,1.16]
Anthropometryc
Body mass index
BMI < 25m/kg2 63.4 [61,65.7] 26.8 [25,28.5] 9.9 [8.7,11.1] n/a n/a
BMI ≥ 25m/kg2 54 [51.9,56.1] 31.9 [30.2,33.6] 14.1 [12.7,15.6] n/a n/a
BMI, m/kg2 n/a n/a n/a 1.03 [1.01,1.05] 1.04 [1.02,1.06]
Waist circumference
WC ≤ 80 cm women, ≤90 cm men 69.6 [67.8,71.5] 22.8 [21.3,24.3] 7.5 [6.6,8.4] n/a n/a
WC > 80 cm women, > 90 cm men 47.8 [45.3,50.2] 35.1 [33.3,36.8] 17.1 [15.5,18.8] n/a n/a
Waist circumference, cm n/a n/a n/a 1.03 [1.02,1.04] 1.05 [1.04,1.06]
Family history of a chronic conditiond
No family history 62.9 [61.2,64.5] 29.4 [27.9,31] 7.7 [7,8.4] Ref Ref
Any family history 56.5 [54.7,58.3] 31.1 [29.4,32.8] 12.4 [11.4,13.4] 1.18 [1.07,1.29] 1.79 [1.58,2.03]
BMI, body mass index; CI, conﬁdence interval; WC, waist circumference.
aThe adjusted prevalence estimates are the predicted marginal prevalence of multimorbidity within groups deﬁned by the covariate.
bThe adjusted prevalence ratios were estimated using a multinomial logistic regression with all covariates shown in the table included simultaneously.
cVariable was divided into categories to estimate adjusted prevalence but was treated as a continuous factor in the prevalence ratio model.
dIncludes family history of hypertension, diabetes or heart disease.
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Table 3 Age-adjusted mortality and mortality hazard ratios associated with multimorbidity, sociodemographic and health-related factors
Variable Age-adjusted
deaths per 1000
person-yearsa
Unadjusted
hazard ratiob
[95% CI]
Age- and sex-
adjusted hazard
ratioc [95% CI]
Fully adjusted
hazard ratiod
[95% CI]
Overall 8.2 [7.3,9.1]
Number of chronic conditionse
0 3.2 [2.2,4.2] Ref Ref Ref
1 3.6 [2.6,4.5] 2.02 [1.41,2.89] 1.11 [0.77,1.59] 1.36 [0.94,1.97]
≥2 5.1 [3.8,6.4] 4.42 [3.12,6.26] 1.65 [1.18,2.32] 2.45 [1.72,3.49]
Agef
Age < 60 years 4.8 [4.1,5.6] n/a n/a n/a
Age ≥ 60 years 31.2 [26.6,36.5] n/a n/a n/a
Age, years n/a 1.08 [1.07,1.09] 1.07 [1.06,1.08] 1.06 [1.05,1.07]
Gender
Men 4.5 [3.3,5.7] Ref Ref Ref
Women 2.9 [2.2,3.6] 0.51 [0.36,0.73] 0.63 [0.47,0.85] 0.91 [0.55,1.52]
Education
Up to primary schooling 5.4 [3.9,7] Ref Ref
High school to secondary 3.7 [2.8,4.6] 0.49 [0.37,0.64] 0.66 [0.48,0.89]
Graduation and above 1.6 [0.9,2.2] 0.20 [0.12,0.32] 0.32 [0.19,0.53]
Occupation
Employed, professional 2.3 [1.3,3.4] Ref Ref
Not in the labor force, student or housewife 2.9 [2.1,3.6] 1.25 [0.75,2.08] 1.03 [0.54,1.98]
Not in the labor force, retired 4.8 [2.7,6.8] 8.84 [5.26,14.85] 1.55 [0.85,2.81]
Unemployed 11.5 [6.6,16.4] 9.60 [5.61,16.41] 2.91 [1.58,5.35]
Employed, manual profession 4.5 [3.0,5.9] 1.73 [1.00,3.00] 1.14 [0.63,2.07]
Current alcohol consumption
No 3.2 [2.5,3.9] Ref Ref
Yes 5.9 [3.5,8.4] 1.63 [1.06,2.49] 1.41 [0.95,2.1]
Current tobacco consumption
No 3.0 [2.4,3.6] Ref Ref
Yes 5.5 [3.8,7.2] 1.91 [1.4,2.6] 1.27 [0.93,1.73]
Anthropometryf
BMI, m/kg2 n/a 0.92 [0.88,0.95] 0.93 [0.87,0.99]
BMI < 25m/kg2 5.1 [3.7,6.5] n/a n/a
BMI ≥ 25m/kg2 2.4 [1.9,2.9] n/a n/a
Waist circumference (WC), cm n/a 0.99 [0.98,1.00] 0.99 [0.97,1.01]
WC ≤ 80 cm women, ≤90 cm men 5.0 [3.8,6.2] n/a n/a
WC > 80 cm women, > 90 cm men 2.6 [2,3.2] n/a n/a
Family historyg
No family history 3.7 [2.9,4.6] Ref Ref
Any family history 3.5 [2.4,4.5] 0.66 [0.48,0.91] 1.22 [0.89,1.66]
BMI, body mass index; CI, conﬁdence interval; WC, waist circumference.
aAge-adjusted deaths per 1000 person-years were computed the predicted rates from Poisson regression models including the covariate of interest and age
groups.
bUnadjusted hazard ratios for mortality were estimated using Cox proportional hazard models adjusted for the complex survey design.
cSex- and age-adjusted hazard ratios for mortality were estimated using Cox proportional hazard models and included only multimorbidity, sex and age.
dFully adjusted hazard ratios for mortality were estimated using Cox proportional hazard models and included multimorbidity, sex, age and all other variables
shown in the table.
eThe presence of hypertension, diabetes, heart disease, chronic kidney disease and stroke were summed for the number of chronic conditions.
fVariable was divided into categories to estimate adjusted mortality rates but was treated as a continuous factor in the adjusted Cox regression model.
gIncludes family history of hypertension, diabetes or heart disease.
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disability levels.17 Adults with multimorbidity also have
more complex care needs which may affect quality of life
and strain carers.20 Additionally, empirical evidence from
around the world suggest that multimorbidity places higher
demand on the health system. It was associated with more
outpatient visits (China); with higher hospital visit expend-
iture (Russia); with greater frequency of hospitalization
(India).21 Patient advocates cite this evidence as the need for
patient-centered care as opposed to disease-centered care.
What this study adds
Our study replicates the positive association between age and
multimorbidity observed in previous studies.22–24 Of the
behavioral risk factors examined, alcohol consumption, BMI
and waist circumference were associated with multimorbid-
ity,25 highlighting the important role of lifestyle factors in the
emergence of multimorbidity. These subgroups may be tar-
geted for screening and appropriate clinical management.
With respect to the social patterning of multimorbidity in
three large South Asian metropolises, we found a nuanced pic-
ture. First, we note that the prevalence of multimorbidity was
over 8% in all subgroups, regardless of educational or occupa-
tional background. However, we found an inverse association
between and education and multimorbidity (i.e. multimorbidity
was less frequent in the most educated adults) but a positive
association between occupational class and multimorbidity (i.e.
service professionals were more likely that those employed in
a manual profession to experience multimorbidity). We note
that the directions of associations for both of these social fac-
tors are consistent across single morbidity and multimorbidity.
The lower prevalence of the examined comorbidities in adults
in manual professions could potentially be due to occupation-
related physical activity, dietary factors, selection of physically
abled individuals in manual professions, or other factors
altogether. While this should be further investigated, it is
beyond the scope of the current study. The differences
between our ﬁndings and past studies may be related to true
differences driven by the urban context, differing conditions
included in the multimorbidity deﬁnition, and variations in
assessment methods (e.g. self-report versus laboratory) used to
identify conditions.
Finally, this is the ﬁrst study examining multimorbidity
and mortality in South Asia. We show that the presence of
multimorbidity substantially affects risk of death independ-
ent of age and other confounding factors.
Strengths and limitations
Strengths of this study include the large and population-
based sample used for the analysis, objective assessment for
several conditions, and prospective follow-up of participants
for mortality outcomes. There were also some limitations.
We were unable to examine the impact of speciﬁc combina-
tions or control status of morbidities on health. We instead
relied on a simple count of diseases as the measure of multi-
morbidity. Our multimorbidity deﬁnition was a relatively
simple measure compared with previous approaches,8,24,26–
29 that did not take severity of disease into account. For dia-
betes, hypertension, and chronic kidney disease, we supple-
mented self-reported prior diagnosis with laboratory
measurements. For heart disease and stroke, however, we
relied exclusively on self-report. These conditions are subject
to measurement error due to under-diagnosis.26–29 Future
investigation may also include other prevalent chronic condi-
tions like cancers, chronic obstructive pulmonary disease,
depression and infectious diseases such as tuberculosis and
HIV as data becomes available. Finally, though the ﬁndings
may generalize to other large metropolises on the subcontin-
ent they may not apply to rural settings where the majority
of the Indian population continues to reside.
Conclusion
This study is a step forward in quantifying the burden of
multimorbidity so that we can develop more coherent set of
responses around multiple co-occurring chronic conditions.
Disease guidelines around the world tend to be developed
for single conditions and fail to account for the multitude of
conditions that may be present in an adult simultaneously.
Conventions to seek specialized treatment for a condition
lead to treatment silos, which can be costly to the health sys-
tem and imprudent for patient care.30 Such guidelines
focused on single morbidity are thus of limited value for the
nearly one in ten adults we observed to have multimorbidity
in three large, ethnically diverse megacities of South Asia.
Given that multimorbidity carries a substantially higher risk
for death than having a single condition, improving our
understanding of how to manage multiple chronic condi-
tions simultaneously in patients could be an important lever-
age point for further progress in life expectancy in India.
Supplementary data
Supplementary data are available at the Journal of Public
Health online.
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